Medicare Enrolled
Dr. Faisal Qazi, D.O.
Neurology · Upland, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Qazi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Qazi?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Qazi
Dr. Faisal Qazi is a neurology specialist in Upland, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Qazi performed 4,554 Medicare services across 1,923 unique beneficiaries.
Between the years covered by Open Payments, Dr. Qazi received a total of $23,066 from 88 pharmaceutical and/or device companies across 1314 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Qazi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 15% volume in CA
$23,066 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,554
Medicare services
Top 15% in CA for neurology
1,923
Unique beneficiaries
$75
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~240 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
1,328 | $53 | $99 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
1,255 | $41 | $75 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
494 | $97 | $180 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
174 | $125 | $225 |
| Psychological test administration, each additional 30 minutes A technician administers psychological or neuropsychological testing. This code covers each additional 30-minute increment of administration time. |
170 | $30 | $60 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
150 | $87 | $130 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
118 | $403 | $581 |
| Neuropsychological test evaluation, first hour A professional assessment of cognitive and behavioral functioning using standardized tests. This service covers the initial hour of the evaluation process. |
112 | $101 | $180 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
92 | $45 | $80 |
| Psychological test administration, first 30 minutes A technician administers psychological or neuropsychological testing for the first 30 minutes. |
91 | $29 | $60 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
74 | $138 | $300 |
| Complete ultrasound of brain blood flow An ultrasound test that evaluates blood flow within the brain's blood vessels. It uses sound waves to create images of the vessels and assess circulation. |
72 | $249 | $340 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
64 | $43 | $75 |
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
59 | $34 | $60 |
| Nerve conduction studies, 13 or more A diagnostic test that measures how well nerves send electrical signals. This code applies when 13 or more individual nerve studies are performed. |
56 | $243 | $425 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
55 | $65 | $100 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
44 | $141 | $330 |
| Electronic analysis of implanted neurostimulator Electronic evaluation of an implanted brain, spinal cord, or peripheral nerve stimulator device. |
40 | $14 | $100 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
28 | $96 | $170 |
| Nerve conduction studies, 11-12 A diagnostic test that measures how well nerves send electrical signals. It involves performing 11 to 12 separate nerve conduction studies. |
26 | $211 | $365 |
| Auditory brainstem response test A test that measures how the brain responds to sound to help diagnose nervous system disorders. The results are interpreted and reported by a medical professional. |
22 | $68 | $125 |
| Remote physiologic monitoring setup and education Initial setup of remote monitoring equipment and patient education on its use. |
18 | $18 | $30 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
12 | $141 | $241 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$23,066
Total received (2018-2024)
Avg $3,295/year across 7 years
Top 14% in CA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
88
Companies
1,314
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$22,303 (96.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$763 (3.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$5,425
2023
$5,478
2022
$3,539
2021
$1,439
2020
$1,024
2019
$2,863
2018
$3,298
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
UCB, Inc.
$853
ABBVIE INC.
$818
Alexion Pharmaceuticals, Inc.
$552
ACADIA Pharmaceuticals Inc
$330
Novartis Pharmaceuticals Corporation
$292
JAZZ PHARMACEUTICALS INC.
$251
Eisai Inc.
$233
PFIZER INC.
$229
Biogen, Inc.
$224
SK Life Science, Inc.
$198
Lundbeck LLC
$196
Amneal Pharmaceuticals LLC
$165
Genentech USA, Inc.
$114
Neurocrine Biosciences, Inc.
$113
ARGENX US, INC.
$107
Lilly USA, LLC
$96
Celgene Corporation
$71
Otsuka America Pharmaceutical, Inc.
$66
MDD US Operations, LLC
$65
EMD Serono, Inc.
$51
LivaNova USA, Inc.
$44
Mallinckrodt Hospital Products Inc.
$42
Kyowa Kirin, Inc.
$41
Takeda Pharmaceuticals U.S.A., Inc.
$41
Vanda Pharmaceuticals Inc.
$38
Octapharma USA, Inc.
$33
Grifols USA, LLC
$28
Sumitomo Pharma America, Inc.
$28
Microtransponder, Inc.
$26
MITSUBISHI TANABE PHARMA AMERICA, INC.
$21
Merz Pharmaceuticals, LLC
$21
SCILEX PHARMACEUTICALS INC.
$20
Abbott Laboratories
$17
Top 3 companies account for 41.0% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$2,332
UCB, Inc.
$1,982
Alexion Pharmaceuticals, Inc.
$1,521
Novartis Pharmaceuticals Corporation
$1,362
ACADIA Pharmaceuticals Inc
$1,212
Biogen, Inc.
$1,091
Teva Pharmaceuticals USA, Inc.
$840
LivaNova USA, Inc.
$654
Sunovion Pharmaceuticals Inc.
$633
SK Life Science, Inc.
$612
Allergan Inc.
$598
JAZZ PHARMACEUTICALS INC.
$525
PFIZER INC.
$520
Allergan, Inc.
$508
Amneal Pharmaceuticals LLC
$485
Neurocrine Biosciences, Inc.
$440
ARGENX US, INC.
$435
Genentech USA, Inc.
$428
Lundbeck LLC
$388
Lilly USA, LLC
$376
Avanir Pharmaceuticals, Inc.
$367
Amgen Inc.
$356
Biohaven Pharmaceutical Holding Company Ltd.
$340
Greenwich Biosciences, Inc.
$318
Eisai Inc.
$299
US WorldMeds, LLC
$284
Otsuka America Pharmaceutical, Inc.
$277
AbbVie Inc.
$253
Biohaven Pharmaceuticals, Inc.
$176
Alnylam Pharmaceuticals Inc.
$160
Kyowa Kirin, Inc.
$155
Akcea Therapeutics, Inc.
$152
CSL Behring
$150
Supernus Pharmaceuticals, Inc.
$141
Takeda Pharmaceuticals U.S.A., Inc.
$135
GENZYME CORPORATION
$124
MDD US Operations, LLC
$120
AbbVie, Inc.
$118
Mallinckrodt LLC
$111
Corium, LLC
$111
Avion Pharmaceuticals
$99
Mallinckrodt Enterprises LLC
$97
Mallinckrodt Hospital Products Inc.
$90
Adamas Pharmaceuticals, Inc.
$87
Sumitomo Pharma America, Inc.
$85
Celgene Corporation
$71
PORTOLA PHARMACEUTICALS, INC.
$71
GRT US Holding, Inc.
$67
Merz Pharmaceuticals, LLC
$65
EISAI INC.
$61
Octapharma USA, Inc.
$61
Impax Laboratories, Inc.
$54
EMD Serono, Inc.
$51
MITSUBISHI TANABE PHARMA AMERICA, INC.
$51
IMPEL PHARMACEUTICALS INC.
$49
Almatica Pharma LLC
$47
Scilex Pharmaceuticals Inc.
$45
Collegium Pharmaceutical, Inc.
$44
Assertio Therapeutics, Inc.
$42
Abbott Laboratories
$42
Grifols USA, LLC
$40
Arbor Pharmaceuticals, Inc.
$40
Vanda Pharmaceuticals Inc.
$38
Azurity Pharmaceuticals, Inc.
$36
Upsher-Smith Laboratories LLC
$34
Mitsubishi Tanabe Pharma America, Inc.
$34
Ipsen Biopharmaceuticals, Inc
$33
Vertical Pharmaceuticals, LLC
$32
Catalyst Pharmaceuticals, Inc.
$31
Retrophin, Inc.
$30
Zimmer Biomet Holdings, Inc.
$30
PORTOLA PHARMACEUTICALS, LLC
$29
Microtransponder, Inc.
$26
Terumo BCT, Inc.
$25
Strongbridge US INC.
$23
Exeltis, USA Inc.
$22
TG THERAPEUTICS, INC.
$20
SCILEX PHARMACEUTICALS INC.
$20
GE Healthcare
$20
Amylyx Pharmaceuticals, Inc.
$19
UPSHER-SMITH LABORATORIES LLC
$17
Bayer HealthCare Pharmaceuticals Inc.
$17
GE HEALTHCARE
$16
Acorda Therapeutics, Inc
$16
Cala Health, Inc.
$16
ASSERTIO THERAPEUTICS, Inc.
$15
Janssen Pharmaceuticals, Inc
$14
Travere Therapeutics, Inc.
$1
Top 3 companies account for 25.3% of all-time payments
Associated products mentioned in payments ›
(820) Cholbam · ACTHAR · ADLARITY · ADUHELM · AFINITOR · AIMOVIG · AJOVY · AMYVID · ANDEXXA · APOKYN · APTIOM · AUBAGIO · AUSTEDO · Adlarity · Aimovig · Austedo XR · BOTOX · BOTOX - NEUROLOGY · BOTOX COSMETIC · BOTOX THERAPEUTIC · BRIUMVI · Betaseron · Biomet Orthopak · Briviact · CALA TRIO · CAMBIA · COMIRNATY · COPAXONE · CREXONT · Cholbam · DUOPA · Dhivy · Duopa · Dysport · ELYXYB - celecoxib · EMGALITY · EPIDIOLEX · EXSERVAN · Epidiolex · Eprontia · FIRDAPSE · Fintepla · Fycompa · GAMMAGARD · GILENYA · GOCOVRI · GRALISE · Gamunex-C · Gocovri · Gralise · HYQVIA · Hizentra · Horizant · INBRIJA · INFINITY · INGREZZA · KESIMPTA · KEVEYIS · KISUNLA · LEMTRADA · LEQEMBI · Leqembi · MAYZENT · MYOBLOC · NAMZARIC · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Neupro · Nourianz · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONFI · ONGENTYS · ONPATTRO · OSMOLEX ER · OXTELLAR XR · Ocrevus · Ongentys · PANZYGA · PONVORY · PURIFIED CORTROPHIN GEL · Ponvory · QELBREE · QULIPTA · Qutenza · RADICAVA · RELYVRIO · REXULTI · RYTARY · Radicava · Rystiggo · SOLIRIS · SPINRAZA · Soliris · Spectra Optia · TECFIDERA · TEGSEDI · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · VNS - Sentiva · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VNS Therapy SenTiva Model 1000 Generator · VRAYLAR · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · XCOPRI · XYWAV · Xadago · Xeomin · ZEPOSIA · ZTLido · Zilbrysq
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Neurologists within 10 mi
159
Per 100K population
7.3
County median income
$82,184
Nearest hospital
SAN ANTONIO REGIONAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Qazi is a clinical cardiology specialist, with above-average Medicare volume (top 15% in CA), with low-engagement industry engagement in the top 14% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Qazi experienced with chronic care management, first 20 min/month?
Based on Medicare claims data, Dr. Qazi performed 1,328 chronic care management, first 20 min/month services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Qazi receive payments from pharmaceutical companies?
Yes. Dr. Qazi received a total of $23,066 from 88 companies across 1,314 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Qazi's costs compare to other neurologists in Upland?
Dr. Qazi's average Medicare payment per service is $75. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Qazi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Upland
Browse neurologists in Upland ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in CA
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in CA
Which CA neurologists receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
By company
Alexion Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Alexion Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology